DETERMINATION OF CANCER ANTIGEN CA15-3 AND ALPHA FETO PROTEIN (AFP) LEVELS AS TUMOR MARKER IN PATIENTS WITH BREAST AND PROSTATE CANCER

Abstract: The objective of the present study is to evaluate the values of cancer antigen (CA15-3) and alpha feto protein (AFP) in patients with breast and prostate cancer. The results revealed the values for CA 15-3 in serum of G1 showed a highly significant increase compared to normal healthy subjects, but CA15-3 in serum of G2 was compatible with control. The results showed the value of serum AFP in G1 (was not significant different) when compared to control, while a highly significant difference in G2 was noticed when compared to healthy subjects.